DXCM

DexCom, Inc.

121.51 USD
+6.44 (+5.60%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

DexCom, Inc. stock is up 0.13% since 30 days ago. The next earnings date is Apr 25, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 63.16% of the previous 18 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
27 Feb 18:42 20 Sep, 2024 100.00 CALL 11 1
27 Feb 18:57 15 Mar, 2024 120.00 CALL 131 2256
27 Feb 20:29 20 Sep, 2024 115.00 CALL 19 6
28 Feb 19:44 20 Sep, 2024 110.00 PUT 36 146
29 Feb 19:01 15 Mar, 2024 115.00 CALL 70 475
01 Mar 15:19 12 Apr, 2024 121.00 CALL 82 0
01 Mar 16:20 21 Jun, 2024 120.00 CALL 200 567
01 Mar 17:06 15 Mar, 2024 127.00 CALL 281 0
01 Mar 17:18 15 Mar, 2024 121.00 CALL 88 30
01 Mar 18:11 15 Mar, 2024 125.00 CALL 100 1873

About DexCom, Inc.

DexCom, Inc. focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system.